⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZYME News
Zymeworks Inc.
Form 8-K
sec.gov
ZYME
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
globenewswire.com
ZYME
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
globenewswire.com
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
globenewswire.com
ZYME
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
globenewswire.com
ZYME
JAZZ
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
globenewswire.com
ZYME
Form 8-K
sec.gov
ZYME
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
globenewswire.com
RPRX
ZYME
Form 8-K
sec.gov
ZYME
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
globenewswire.com
RPRX
ZYME